Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum-Reference-Cited by-同舟云学术

Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum

Published:2020-12-01 Issue:12 Volume:156 Page:1315
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Eichenfield Lawrence F.¹²,McFalda Wendy³,Brabec Bradford⁴,Siegfried Elaine⁵,Kwong Pearl⁶,McBride Mark⁷,Rieger Jayson⁸,Willson Cynthia⁸,Davidson Matthew⁸,Burnett Patrick⁸

Affiliation:

1. School of Medicine, University of California, San Diego

2. Department of Dermatology, Rady Children’s Hospital, San Diego, California

3. Clarkston Skin Research, Clarkston, Michigan

4. Midwest Children’s Health Research Institute, Lincoln, Nebraska

5. Department of Pediatrics, St Louis University, St Louis, Missouri

6. Solutions Through Advanced Research, Jacksonville, Florida

7. Instat Consulting, Inc, Chatham, New Jersey

8. Verrica Pharmaceuticals Inc, West Chester, Pennsylvania

Publisher

American Medical Association (AMA)

Subject